← Leaderboards
Darin E. Jones
Washington University
$872,084
Attributed
$1,744,167
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $370.6K · FY2016–20$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,744,167 · 1
By mechanism
R01$1,744,167 · 1
Top collaborators
- John A Tainer3 shared
- Zamal Ahmed2 shared
- Tom E. Ellenberger1 shared
Most similar at Washington University
Same institution · by research overlap
- Jeffrey D Milbrandt$49,168,006
- Aaron Diantonio$22,295,046
- Rodney D Newberry$20,614,090
- Tamara L Doering$20,134,929
- Gabriel Mbalaviele$7,231,329
Others in their field
Top investigators on “Defect”
- Lawrence Corey · Fred Hutchinson Cancer Center$207,121,712
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$110,264,229
- William George Nelson · Johns Hopkins University$80,153,436
- John A Tainer · Scripps Research Institute$73,493,996
- Stacey Gabriel · Massachusetts Institute Of Technology$48,168,194
- Steven G. Self · Fred Hutchinson Cancer Research Center$43,947,468
Research focus
DefectDesignChemosensitizing AgentCultured CellsChemotherapyAnalogChemical SynthesisBaseChemotherapy-Oncologic ProcedureComplementBiochemicalAcute ToxicityBrca1 GeneBrca2 GeneActive SitesBreast Cancer TreatmentCancer CellCancer TherapyCell DeathBindingCell LineBinding SitesCellsDna Damage
Grant awards (6)
PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM$345,984
R01 · FY2020 · CA
PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM$335,603
R01 · FY2019 · CA
PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM$345,984
R01 · FY2018 · CA
PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM$345,984
R01 · FY2017 · CA
PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM$331,712
R01 · FY2016 · CA
PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM$38,900
R01 · FY2016 · CA